DRALSERP (HYDRALAZINE HYDROCHLORIDE; RESERPINE) — FDA Approval ANDA084617 (SANDOZ)
DRALSERP (HYDRALAZINE HYDROCHLORIDE; RESERPINE) — FDA Approval ANDA084617 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: DRALSERP; Active ingredients: HYDRALAZINE HYDROCHLORIDE; RESERPINE; Application number: ANDA084617.
| Brand name | DRALSERP |
|---|---|
| Active ingredients | HYDRALAZINE HYDROCHLORIDE; RESERPINE |
| Application number | ANDA084617 |
| Sponsor | SANDOZ |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19940916 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →